1142. Plasma with high titers of anti-SARS-Cov2 antibodies improves outcome of COVID-19 in patients with hematological malignancy and cancer in a randomized controlled trial

Claudia M. Denkinger, Carsten Müller‐Tidow, Ulrike Schäkel et al.|Open Forum Infectious Diseases|2022

Cited by 0